Indian peptide therapeutics market will see a considerable growth of 7.6% during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs.
India is providing new growth opportunities for the peptide therapeutics market expansion in the generic peptide drug and API market. Moreover, custom peptide synthesis services are gaining huge traction in India. Several local healthcare companies are offering custom peptide synthesis services. USV Pvt. Ltd., TCI Chemicals (India) Pvt. Ltd., Biotech Desk Pvt Ltd., Life Technologies (India) Pvt Ltd., GenPro Biotech are some of the players in the Indian peptide therapeutics market, offering custom peptide synthesis services.
A full Report of Indian Peptide Therapeutics Market Available athttps://www.omrglobal.com/industry-reports/indian-peptide-therapeutics-market
The companies are offering their custom peptide synthesis services to the biomedical research community, biotechnology, and pharmaceutical industry. Along with the companies, the National Institute for Research in Reproductive Health (NIRRH), has a dedicated resource for the chemical synthesis of peptides of required amino acid sequences.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-peptide-therapeutics-market
The users are expected to offer the sequence of the peptides (up to 20 residues max) that are required to be synthesized. The purified synthetic peptides are offered in dried form along with the RP-HPLC profiles, MALDI-TOF spectra, and amino acid composition of the synthesized peptide. Therefore, combinedly, the research institutes and market players are driving the peptide synthesis services in India, which in turn, is escalating the
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
India Peptide Therapeutics Market – Segmentation
By Route of Administration
- Metabolic Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others (Kidney Disorder and Autoimmune Disorder)
- AstraZeneca PLC
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Flagship Biotech International Pvt. Ltd.
- GlaxoSmithKline PLC
- Hemmo Pharmaceuticals Pvt. Ltd.
- Lyotex Lifesciences Pvt Ltd.
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/indian-peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404